Ward SA, Parikh S, Workman B. Health perspectives: international epidemiology of ageing. Best Prac Res Clin Anaesthesiol 2011;25:305–17. https://doi.org/10.1016/j.bpa.2011.05.002.
DOI: 10.1016/j.bpa.2011.05.002
Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022;7:e105–25. https://doi.org/10.1016/S2468-2667(21)00249-8.
DOI: 10.1016/S2468-2667(21)00249-8
Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. Health, functioning, and disability in older adults - Present status and future implications. The Lancet 2015;385:563–75. https://doi.org/10.1016/S0140-6736(14)61462-8.
DOI: 10.1016/S0140-6736(14)61462-8
Craik FI, Bialystok E. Cognition through the lifespan: mechanisms of change. Trends Cogn Sci 2006;10:131–8. https://doi.org/10.1016/j.tics.2006.01.007.
DOI: 10.1016/j.tics.2006.01.007
Tucker-Drob EM. Global and domain-specific changes in cognition throughout adulthood. Dev Psychol 2011;47:331–43. https://doi.org/10.1037/a0021361.
DOI: 10.1037/a0021361
Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: mild cognitive impairment report of the guideline development, dissemination, and implementation. Neurology 2018;90:126–35. https://doi.org/10.1212/WNL.0000000000004826.
DOI: 10.1212/WNL.0000000000004826
Cao Q, Tan CC, Xu W, Hu H, Cao XP, Dong Q, et al. The prevalence of dementia: a systematic review and meta-analysis. J Alzheimers Dis 2020;73:1157–66. https://doi.org/10.3233/JAD-191092.
DOI: 10.3233/JAD-191092
Jung AR, Kim D, Park EA. Cognitive intervention using information and communication technology for older adults with mild cognitive impairment: a systematic review and meta-analysis. Int J Environ Res Public Health 2021;18:11535. https://doi.org/10.3390/ijerph182111535.
DOI: 10.3390/ijerph182111535
Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev 2013;12:263–75. https://doi.org/10.1016/j.arr.2012.07.003.
DOI: 10.1016/j.arr.2012.07.003
Kelly ME, Loughrey D, Lawlor BA, Robertson IH, Walsh C, Brennan S. The impact of cognitive training and mental stimulation on cognitive and everyday functioning of healthy older adults: a systematic review and meta-analysis. Ageing Res Rev 2014;15:28–43. https://doi.org/10.1016/j.arr.2014.02.004.
DOI: 10.1016/j.arr.2014.02.004
Coelho-Junior H, Marzetti E, Calvani R, Picca A, Arai H, Uchida M. Resistance training improves cognitive function in older adults with different cognitive status: a systematic review and meta-analysis. Aging Ment Health 2022;26:213–24. https://doi.org/10.1080/13607863.2020.1857691.
DOI: 10.1080/13607863.2020.1857691
Popa-Wagner A, Dumitrascu D, Capitanescu B, Petcu E, Surugiu R, Fang WH, et al. Dietary habits, lifestyle factors and neurodegenerative diseases. Neural Regen Res 2020;15:394–400. https://doi.org/10.4103/1673-5374.266045.
DOI: 10.4103/1673-5374.266045
Gutierrez L, Folch A, Rojas M, Cantero JL, Atienza M, Folch J, et al. Effects of nutrition on cognitive function in adults with or without cognitive impairment: a systematic review of randomized controlled clinical trials. Nutrients 2021;13:3728. https://doi.org/10.3390/nu13113728.
DOI: 10.3390/nu13113728
Rahman MH, Akter R, Bhattacharya T, Abdel-Daim MM, Alkahtani S, Arafah MW, et al. Resveratrol and neuroprotection: impact and its therapeutic potential in Alzheimer’s disease. Front Pharmacol 2020;11:619024. https://doi.org/10.3389/fphar.2020.619024.
DOI: 10.3389/fphar.2020.619024
Albani D, Polito L, Signorini A, Forloni G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. BioFactors 2010;36:370–6. https://doi.org/10.1002/biof.118.
DOI: 10.1002/biof.118
dos Santos MG, Schimith LE, André-Miral C, Muccillo-Baisch AL, Arbo BD, Hort MA. Neuroprotective effects of resveratrol in In vivo and In vitro experimental models of Parkinson’s disease: a systematic review. Neurotox Res 2022;40:319–45.
DOI: 10.1007/s12640-021-00450-x
Riccio BVF, Spósito L, Carvalho GC, Ferrari PC, Chorilli M. Resveratrol isoforms and conjugates: A review from biosynthesis in plants to elimination from the human body. Arch Pharm (Weinheim). 2020;353(12):e2000146.
DOI: 10.1002/ardp.202000146
Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochim Biophys Acta 2015;1852:1195–201. https://doi.org/10.1016/j.bbadis.2014.09.011.
DOI: 10.1016/j.bbadis.2014.09.011
Ramírez-Garza SL, Laveriano-Santos EP, Marhuenda-Muñoz M, Storniolo CE, Tresserra-Rimbau A, Vallverdú-Queralt A, Lamuela-Raventós RM. Health Effects of Resveratrol: Results from Human Intervention Trials. Nutrients. 2018;10(12):1892.
DOI: 10.3390/nu10121892
Terracina S, Petrella C, Francati S, Lucarelli M, Barbato C, Minni A, Ralli M, Greco A, Tarani L, Fiore M, Ferraguti G. Antioxidant Intervention to Improve Cognition in the Aging Brain: The Example of Hydroxytyrosol and Resveratrol. Int J Mol Sci. 2022 Dec 10;23(24):15674.
DOI: 10.3390/ijms232415674
Gomes BA, Silva JP, Romeiro CF, dos Santos SM, Rodrigues CA, Gonçalves PR, et al. Neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1. Oxid Med Cell Longev 2018;2018:8152373. https://doi.org/10.1155/2018/8152373.
DOI: 10.1155/2018/8152373
Islam F, Nafady MH, Islam MR, Saha S, Rashid S, Akter A, Or-Rashid MH, Akhtar MF, Perveen A, Md Ashraf G, Rahman MH, Hussein Sweilam S. Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside. Mol Neurobiol. 2022;59(7):4384-4404.
DOI: 10.1007/s12035-022-02859-7
Dias GP, Cocks G, do Nascimento Bevilaqua MC, Nardi AE, Thuret S. Resveratrol: a potential hippocampal plasticity enhancer. Oxid Med Cell Longev 2016;2016:9651236. https://doi.org/10.1155/2016/9651236.
DOI: 10.1155/2016/9651236
Khorshidi F, Poljak A, Liu Y, Lo JW, Crawford JD, Sachdev PS. Resveratrol: a “miracle” drug in neuropsychiatry or a cognitive enhancer for mice only? a systematic review and meta-analysis. Ageing Res Rev 2021;65:101199. https://doi.org/10.1016/j.arr.2020.101199.
DOI: 10.1016/j.arr.2020.101199
Dal-Pan A, Pifferi F, Marchal J, Picq JL, Aujard F. Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate. PLoS One 2011;6:e16581. https://doi.org/10.1371/journal.pone.0016581.
DOI: 10.1371/journal.pone.0016581
Farzaei MH, Rahimi R, Nikfar S, Abdollahi M. Effect of resveratrol on cognitive and memory performance and mood: a meta-analysis of 225 patients. Pharmacol Res 2018;128:338–44. https://doi.org/10.1016/j.phrs.2017.08.009.
DOI: 10.1016/j.phrs.2017.08.009
Marx W, Kelly JT, Marshall S, Cutajar J, Annois B, Pipingas A, et al. Effect of resveratrol supplementation on cognitive performance and mood in adults: a systematic literature review and meta-analysis of randomized controlled trials. Nutr Rev 2018;76:432–43. https://doi.org/10.1093/nutrit/nuy010.
DOI: 10.1093/nutrit/nuy010
Wightman EL, Haskell-Ramsay CF, Reay JL, Williamson G, Dew T, Zhang W, et al. The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans. Br J Nutr. 2015;114(9):1427-37.
DOI: 10.1017/S0007114515003037
Wong RHX, Berry NM, Coates AM, Buckley JD, Bryan J, Kunz I, et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens 2013;31:1819–27. https://doi.org/10.1097/HJH.0b013e328362b9d6.
DOI: 10.1097/HJH.0b013e328362b9d6
Zortea K, Franco VC, Guimarães P, Belmonte-de-Abreu PS. Resveratrol supplementation did not improve cognition in patients with schizophrenia: results from a randomized clinical trial. Front Psychiatry 2016;7:159. https://doi.org/10.3389/fpsyt.2016.00159.
DOI: 10.3389/fpsyt.2016.00159
Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010;91:1590–7. https://doi.org/10.3945/ajcn.2009.28641.
DOI: 10.3945/ajcn.2009.28641
Scholey A, Benson S, Stough C, Stockley C. Effects of resveratrol and alcohol on mood and cognitive function in older individuals. Nutr Aging 2014;2:133–8. https://doi.org/10.3233/nua-130037.
DOI: 10.3233/NUA-130037
Wong RHX, Raederstorff D, Howe PRC. Acute resveratrol consumption improves neurovascular coupling capacity in adults with type 2 diabetes mellitus. Nutrients 2016;8:495. https://doi.org/10.3390/nu8070425.
DOI: 10.3390/nu8070425
Salthouse TA. Trajectories of normal cognitive aging. Psychol Aging 2019;34:17–24. https://doi.org/10.1037/pag0000288.
DOI: 10.1037/pag0000288
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700. https://doi.org/10.1136/bmj.b2700.
DOI: 10.1136/bmj.b2700
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98. https://doi.org/10.1016/0022-3956(75)90026-6.
DOI: 10.1016/0022-3956(75)90026-6
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9. https://doi.org/10.1111/j.1532-5415.2005.53221.x.
DOI: 10.1111/j.1532-5415.2005.53221.x
Centro Cochrane Iberoamericano. Manual Cochrane de Revisiones Sistemáticas de Intervenciones, versión 5.1.0. Barcelona: Centro Cochrane Iberoamericano; 2012.
Zhu CW, Grossman H, Neugroschl J, Parker S, Burden A, Luo X, et al. A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer’s disease: a pilot study. Alzheimers Dement (N Y) 2018;9:609–16. https://doi.org/10.1016/j.trci.2018.09.009.
DOI: 10.1016/j.trci.2018.09.009
Moran C, Scotto di Palumbo A, Bramham J, Moran A, Rooney B, de Vito G, et al. Effects of a six-month multi-ingredient nutrition supplement intervention of omega-3 polyunsaturated fatty acids, vitamin D, resveratrol, and whey protein on cognitive function in older adults: a randomised, double-blind, controlled trial. J Prev Alzheimers Dis 2018;5:175–83. https://doi.org/10.14283/jpad.2018.11.
DOI: 10.14283/jpad.2018.11
Lee J, Torosyan N, Silverman DH. Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: a double-blinded placebo controlled pilot study. Exp Gerontol 2017;87:121–8. https://doi.org/10.1016/j.exger.2016.10.004.
DOI: 10.1016/j.exger.2016.10.004
Cimrová B, Budáč S, Melicherová U, Jergelová M, Jagla F. Electrophysiological evidence of the effect of natural polyphenols upon the human higher brain functions. Neuro Endocrinol Lett 2011;32:464–8.
[44] Wong RHX, Nealon RS, Scholey A, Howe PRC. Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2016;26:393–9. https://doi.org/10.1016/j.numecd.2016.03.003.
DOI: 10.1016/j.numecd.2016.03.003
Wightman EL, Reay JL, Haskell CF, Williamson G, Dew TP, Kennedy DO. Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: A randomised, double-blind, placebo-controlled, cross-over investigation. Br J Nutr 2014;112:203–13. https://doi.org/10.1017/S0007114514000737.
DOI: 10.1017/S0007114514000737
Thaung JJ, Howe PRC, Wong RHX. Sustained cerebrovascular and cognitive benefits of resveratrol in postmenopausal women. Nutrients 2020;12:828. https://doi.org/10.3390/nu12030828.
DOI: 10.3390/nu12030828
Thaung JJ, Howe PRC, Wong RHX. Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: a 24-month randomised, double-blind, placebo-controlled, crossover study. Clin Nutr 2021;40:820–9. https://doi.org/10.1016/j.clnu.2020.08.025.
DOI: 10.1016/j.clnu.2020.08.025
Evans HM, Howe PRC, Wong RHX. Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial. Nutrients 2017;9:27. https://doi.org/10.3390/nu9010027.
DOI: 10.3390/nu9010027
Anton SD, Ebner N, Dzierzewski JM, Zlatar ZZ, Gurka MJ, Dotson VM, et al. Effects of 90 days of resveratrol supplementation on cognitive function in elders: A pilot study. J Altern Complement Med 2018;24:725–32. https://doi.org/10.1089/acm.2017.0398.
DOI: 10.1089/acm.2017.0398
Köbe T, Witte AV, Schnelle A, Tesky VA, Pantel J, Schuchardt JP, et al. Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment. Front Neurosci 2017;11:105. https://doi.org/10.3389/fnins.2017.00105.
DOI: 10.3389/fnins.2017.00105
Huhn S, Beyer F, Zhang R, Lampe L, Grothe J, Kratzsch J, et al. Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults – A randomized controlled trial. Neuroimage 2018;174:177–90. https://doi.org/10.1016/j.neuroimage.2018.03.023.
DOI: 10.1016/j.neuroimage.2018.03.023
Witte VA, Kerti L, Margulies DS, Flöel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci 2014;34:7862–70. https://doi.org/10.1523/JNEUROSCI.0385-14.2014.
DOI: 10.1523/JNEUROSCI.0385-14.2014
Corpas R, Griñán-Ferré C, Rodríguez-Farré E, Pallàs M, Sanfeliu C. Resveratrol induces brain resilience against Alzheimer neurodegeneration through proteostasis enhancement. Mol Neurobiol 2019;56:1502–16. https://doi.org/10.1007/s12035-018-1157-y.
DOI: 10.1007/s12035-018-1157-y
Wang R, Zhang Y, Li J, Zhang C. Resveratrol ameliorates spatial learning memory impairment induced by Aβ1–42 in rats. Neuroscience 2017;344:39–47. https://doi.org/10.1016/j.neuroscience.2016.08.051.
DOI: 10.1016/j.neuroscience.2016.08.051
Zhao YN, Li WF, Li F, Zhang Z, Dai YD, Xu AL, et al. Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway. Biochem Biophys Res Commun 2013;435:597–602. https://doi.org/10.1016/j.bbrc.2013.05.025.
DOI: 10.1016/j.bbrc.2013.05.025
Smoliga JM, Blanchard O. Enhancing the delivery of resveratrol in humans: If low bioavailability is the problem, what is the solution? Molecules 2014;19:17154–72. https://doi.org/10.3390/molecules191117154.
DOI: 10.3390/molecules191117154
Chimento A, de Amicis F, Sirianni R, Sinicropi MS, Puoci F, Casaburi I, et al. Progress to improve oral bioavailability and beneficial effects of resveratrol. Int J Mol Sci 2019;20:1381. https://doi.org/10.3390/ijms20061381.
DOI: 10.3390/ijms20061381
de Vries K, Strydom M, Steenkamp V. A brief updated review of advances to enhance resveratrol’s bioavailability. Molecules 2021;26:4367. https://doi.org/10.3390/molecules26144367.
DOI: 10.3390/molecules26144367
Chachay VS, Kirkpatrick CM, Hickman IJ, Ferguson M, Prins JB, Martin JH. Resveratrol--pills to replace a healthy diet? Br J Clin Pharmacol. 2011;72(1):27-38.
DOI: 10.1111/j.1365-2125.2011.03966.x